Dr. Marc Hentz
Associate Partner (Biotech, Life Science & Pharma)
Dr. Marc Hentz has more than 20 years experience in top management consulting, venture capital and high technology. Managed numerous projects in Strategy, Business Planning, BPR, Procurement, Restructuring and Supply Chain Management as well as the set-up and financing of international biotech and chemical organisations.
Industry expertise especially in the Pharmaceutical and Biotech sectors, Chemical, Oil & Gas. Previously with A.T. Kearney as well as with the Industrial Investment Council and Biopolis & Company. Dr Hentz has held various board seats of biotech firms (including Chairman of the Board of RNAi firm Cenix Bioscience) and VC & PE funds.
Previous to Lansdowne, Marc worked at A.T. Kearney before establishing a successful biotech and pharma consultancy. He speaks English, French and German.
Marc holds a Diploma from the University of Hamburg and the University of California and a Ph.D. in Molecular Biology from University of Hamburg and Yale University.